B6EU02 AF NFT

Bifunctional helicase and thymine dioxygenase JBP2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigld72o52rxpe7unexurdpiuoztvoifhmoexxw26byk6jcqzczsr4/metadata.json
IPFS of structure file: 
bafybeifuei34h7uuviwornfff7kowmymqpb4qqws7lfjiki6jlbwgrjw4i/AF-B6EU02-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x00441461d82e7A5044F490FDBF5573Ac7C62b4d8
First NFT owner address (bech32): 
genesis1qpzpgcwc9ea9q385jr7m74tn437x9dxce6hct2
Current NFT ID #196264 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
196264
Accession (UniProt):
B6EU02
Name::
Bifunctional helicase and thymine dioxygenase JBP2
Experimental Method:
Predicted structure
Sequence source:
LEISHMANIA TARENTOLAE

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B6EU02 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B6EU02|JBP2_LEITA Bifunctional helicase and thymine dioxygenase JBP2 OS=Leishmania tarentolae OX=5689 GN=JBP2 PE=1 SV=1 MLNGLTRVSTSSELESILDIVQSSGEIAVVFISPSIGDLETITSETQRRQLRIAGIPRGGYTILPAIPLYDDELLQMCERYTAANDYEKAQIRDSLFMREYPLFAYSVRNHKALFHPADYVSRILQFCSYYVQAPDADVLSLLDRSPFLHISPIKEICTHIRLIARGTPLAPEDSESPAPEQLRFHAESDAEKLAAERAGAMSIATSSGGASETEQLSLFSGVVPSALFQKDAVEEVDKDTEETMVDLTGEETVDAVHSFQAEYLTLDGLELVTKAAIFYDREGEGQRIVAVYIPGGVPEDTCRAAAAVLEPAATKKNLRALTNGGLPPDTGLVGYYDYLTNPTRHKCRETEFSRRNWGLLAQSEPLLKHLDKLYSQLAPMHHHLQKVAIPSQYQLCGTVFSTITVNRNFRTAVHTDKGDFRSGLGVLSVINGEFEGCHLAIKKLKKAFQLKVGDVLLFDTSLEHGNTEVINPEIHWQRTSIVCYLRTGLMSSVCEMERRKHLNRLILQQLRNTEVLNTTVNINGADSSLPPLFVPTRLASHLAPVQLAALGFIVERTEKQSGCVVAMTMGLGKTLVALTLCFSQLHLAPQADILILTPKPIISHWVDEKNKWAMHGLHFPHFVASDGLNSLEFEQQLLEYERQKNNEKPKLGHVFVINGEYLAGFLRRFKRFTPLLIIVDEGHRVAAKGNKLTESLDRLRCNLRIVLSGTPLQNDASELYRLVGWVNKGVGRVLPPKRFQELANDINQFVEGDDGAFYNAVMAQEYIQDWMRGFVFREMENDLPPLHDYLLICGSSDVQREYEEKLGLTETTMTALKATEHRPHHLSTHPACYLAFISDSYQSMVSGWTVRAQANTSRMRVSQLEEIDTMRLEHYVQMVENEQLDTFIDLSGKMRVLVDIVLRVQARKEKLIIFSLYVGSQDLIHRTLTALRVCTFTVRGRDSQDRRRRAMQEFSENKDLIVLVLSTKIAAYGLDFTAANHVVLFDSWWNPQVDAQAIARAYRRNQRKPVTVYRLISATENKFVLSSQTRKIALFKCILHERTSRQALPDELEDCAANEKDEERRSFWAKLKTTLLAGGTRALLNVYRYQESVRESE